◆ 会议时间:2021年9月30日至10月2日
◆ 会议地点:日本 横滨 - Pacific Convention Plaza Yokohama(PACIFICO Yokohama)
◆ 会议简介:
2021年第80届日本癌症协会(JCA)年会将于2021年9月30日至10月2日在日本横滨举行,会议由日本癌症协会(JCA)主办。日本癌症协会(JCA)成立于1941年,其宗旨是通过主办年会及其他学术会议、出版刊物等宣促进癌症研究,JCA现拥有15000余名成员。——未经本站许可,禁止复制摘录本站任何内容-领域国际医学会议网。
第80回日本癌学会学術総会
The 80th Annual Meeting of the Japanese Cancer Association
Date |
September 30 (Thu.) – October 2 (Sat.), 2021 |
Venue |
Pacific Convention Plaza Yokohama(PACIFICO Yokohama)
1-1-1, Minato Mirai, Nishi-ku, Yokohama 220-0012, JAPAN |
Theme |
80年を超え、がん撲滅の願いを未来へ
Bringing hope for future cancer eradication, building on the past 80 years |
Congress
President |
Hideyuki Saya, M. D., Ph. D.
Professor, Division of Gene Regulation, Institute for Advanced Medical Research,
Graduate School of Medicine, Keio University |
摘要:
Session |
Deadline |
Core Symposia
International Sessions
Symposia |
April 8th (Thu), 2021, 12:00 p.m. (JST)*1 *2
Extended until April 22nd (Thu), 2021, 12:00 p.m. (JST) |
Oral session
Poster Presentation |
April 22nd (Thu), 2021, 12:00 p.m. (JST)
Extended until May 17th (Mon), 2021, 12:00 p.m. (JST) |
Greeting from the President
I am pleased to announce that the 80th Annual Meeting of the Japanese Cancer Association will be held at Pacifico Yokohama for three days from September 30 (Thursday) to October 2 (Saturday), 2021. First held in Osaka in 1941, the annual meeting has been convened continuously for these 80 years, except when forced to cancel because of World War II. The forthcoming commemorative 80th Annual Meeting will be held on the theme, “Bringing hope for future cancer eradication, building on the past 80 years.” Cutting-edge knowledge and technologies are expected to bring dramatic progress in the diagnosis and treatment of cancer, and are built upon the efforts and achievements of our predecessors. In the forthcoming meeting, therefore, we will look back on the wealth of such accumulated knowledge with gratitude and discuss new strategies to eradicate cancer by applying innovative technologies to overcome the difficulties faced by our predecessors.
The key mission of the Japanese Cancer Association is to win the battle against cancer through basic research. However, there is an obstacle to translating discoveries from basic research to clinical application, known as “the Valley of Death,” and many cancer researchers have been disheartened by the depth of that valley. On the other hand, interdisciplinary collaboration among researchers in various rapidly-evolving fields has given rise to new scientific fields of study, and has had a tangible impact on the diagnosis and treatment of cancer. The involvement of specialists in a diverse range of studies, encompassing natural, human and social sciences, helps to overcome this obstacle in terms of both time and space, and drive the integration of basic research and clinical application. The development of innovative diagnosis and treatment methods requires collaboration across different disciplines, fields and professions, and such interdisciplinary efforts may enable some small discovery to suddenly win the battle against cancer.
The 80th Annual Meeting will be organized as an experimental forum where specialists in various fields, including corporate people, are brought together with the mission of eradicating cancer, and exploring how research ideals and hypotheses can be turned into reality. We thus hope to build a basis for organic partnerships among academia, industry and society to enable stakeholders with diverse backgrounds to think and work together. In addition, we will organize the meeting in a manner that captures the interest of young researchers and students, who will be the next generation of oncology leaders, and makes them want to participate. We will also build on the globalization efforts of preceding meetings to present a new form of globalization at the meeting.
Although the state of the Covid-19 pandemic by the time of the annual meeting is unclear, we hope to welcome you in person in Yokohama. We very much look forward to your participation and highly appreciate your valuable contribution to the presentations and discussions.
Hideyuki SAYA, M.D., Ph.D.
President, The 80th Annual Meeting of the Japanese Cancer Association Professor,
Division of Gene Regulation, Institute for Advanced Medical Research,
Graduate School of Medicine, Keio University
注册费:
Registration period
Tuesday, June 1st 12:00 (JST) ~ Friday, July 30th 12:00 (JST), 2021
※If you are the lead presenter of an open call or general abstract, please make sure to complete the admission procedure during the registration period and register as a member status in advance.
※For honorary members, we will send invitation individually, so there is no need to register online in advance.
Registration fee
JPY 3,000(Overseas) - 国际与会者
This registration fee applies to participants who reside outside of Japan without Japanese nationality.
For the participants who reside in Japan, the following registration fee is applied.
日本国内参会者 |
Pre-registration |
On-site registration |
Member
(tax free) |
General Participant |
JPY 12,000 |
JPY 15,000 |
Graduate Student |
JPY 3,000 |
JPY 4,000 |
Undergraduate student |
free |
free |
Non-member
(tax included) |
General |
JPY 25,000 |
JPY 30,000 |
Graduate Student |
JPY 7,000 |
JPY 8,000 |
Undergraduate student |
free |
free |
※Payment should be made in Japanese yen.
※We do not accept registration by telephone, fax or email.
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|